These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Inflammation and autoimmunity are interrelated in patients with sickle cell disease at a steady-state condition: implications for vaso-occlusive crisis, pain, and sensory sensitivity. Li W; Pucka AQ; Debats C; Reyes BA; Syed F; O'Brien ARW; Mehta R; Manchanda N; Jacob SA; Hardesty BM; Greist A; Harte SE; Harris RE; Yu Q; Wang Y Front Immunol; 2024; 15():1288187. PubMed ID: 38361924 [TBL] [Abstract][Full Text] [Related]
9. Hypercoagulability in Sickle Cell Disease: A Thrombo-Inflammatory Mechanism. Hamali HA Hemoglobin; 2023 Nov; 47(6):205-214. PubMed ID: 38189099 [TBL] [Abstract][Full Text] [Related]
10. The Red Blood Cell-Inflammation Vicious Circle in Sickle Cell Disease. Nader E; Romana M; Connes P Front Immunol; 2020; 11():454. PubMed ID: 32231672 [TBL] [Abstract][Full Text] [Related]
11. Olinciguat, a stimulator of soluble guanylyl cyclase, attenuates inflammation, vaso-occlusion and nephropathy in mouse models of sickle cell disease. Tchernychev B; Li H; Lee SK; Gao X; Ramanarasimhaiah R; Liu G; Hall KC; Bernier SG; Jones JE; Feil S; Feil R; Buys ES; Graul RM; Frenette PS; Masferrer JL Br J Pharmacol; 2021 Sep; 178(17):3463-3475. PubMed ID: 33864386 [TBL] [Abstract][Full Text] [Related]
12. Dynamics of von Willebrand factor reactivity in sickle cell disease during vaso-occlusive crisis and steady state. Sins JWR; Schimmel M; Luken BM; Nur E; Zeerleder SS; van Tuijn CFJ; Brandjes DPM; Kopatz WF; Urbanus RT; Meijers JCM; Biemond BJ; Fijnvandraat K J Thromb Haemost; 2017 Jul; 15(7):1392-1402. PubMed ID: 28457019 [TBL] [Abstract][Full Text] [Related]
14. Markers of endothelial dysfunction and leucocyte activation in Saudi and non-Saudi haplotypes of sickle cell disease. Al Najjar S; Adam S; Ahmed N; Qari M Ann Hematol; 2017 Jan; 96(1):141-146. PubMed ID: 27686084 [TBL] [Abstract][Full Text] [Related]
15. Pathways to pulmonary hypertension in sickle cell disease: the search for prevention and early intervention. Shilo NR; Morris CR Expert Rev Hematol; 2017 Oct; 10(10):875-890. PubMed ID: 28817980 [TBL] [Abstract][Full Text] [Related]
16. Vasculopathy in Sickle Cell Disease: From Red Blood Cell Sickling to Vascular Dysfunction. Nader E; Conran N; Romana M; Connes P Compr Physiol; 2021 Apr; 11(2):1785-1803. PubMed ID: 33792905 [TBL] [Abstract][Full Text] [Related]
17. Investigation of thrombin generation assay to predict vaso-occlusive crisis in adulthood with sickle cell disease. Feugray G; Kasonga F; Grall M; Dumesnil C; Benhamou Y; Brunel V; Le Cam Duchez V; Lahary A; Billoir P Front Cardiovasc Med; 2022; 9():883812. PubMed ID: 36277754 [TBL] [Abstract][Full Text] [Related]
18. Pathophysiology of Sickle Cell Disease. Sundd P; Gladwin MT; Novelli EM Annu Rev Pathol; 2019 Jan; 14():263-292. PubMed ID: 30332562 [TBL] [Abstract][Full Text] [Related]
19. Risk of vaso-occlusive episodes in patients with sickle cell disease exposed to systemic corticosteroids: a comprehensive review. Ferreira de Matos C; Comont T; Castex MP; Lafaurie M; Walter O; Moulis G; Dion J; Cougoul P Expert Rev Hematol; 2022 Dec; 15(12):1045-1054. PubMed ID: 36412212 [TBL] [Abstract][Full Text] [Related]
20. Sickle Cell Disease: Reappraisal of the Role of Foetal Haemoglobin Levels in the Frequency of Vaso-Occlusive Crisis. Antwi-Boasiako C; Frimpong E; Ababio GK; Dzudzor B; Ekem I; Gyan B; Sodzi-Tettey NA; Antwi DA Ghana Med J; 2015 Jun; 49(2):102-6. PubMed ID: 26339094 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]